A 3D printing ink for preparing a high-strength stent with an interconnected pore structure, and a preparation method and application thereof
Ink is prepared by freeze-drying method of modified octa-calcium phosphate powder and sodium alginate powder, and bone repair stents are prepared by 3D printing technology, which solves the problems of stent structure damage and insufficient mechanical properties, and achieves biocompatibility and mechanical strength. It improves, meeting the porous structure and mechanical properties requirements of bone repair stents.
Patent Information
- Application Number
- CN202211364482.X
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2022-11-02
- Publication Date
- 2024-11-12
- Estimated Expiration
- 2042-11-02
AI Technical Summary
The existing bone tissue engineering stents are damaged during drying, and cannot maintain an interconnected porous structure, which affects its application prospects. The mechanical properties of the organic/inorganic composite stents are insufficient, making it difficult to be used for bone defect repair in load-bearing areas.
The foamy solid was prepared by freeze-drying by modifying octa-calcium phosphate powder and sodium alginate powder, mixed with deionized water to make ink, and a bone repair scaffold with interconnected pore structure was prepared by 3D printing technology, using tannin acid and shell Glycans encapsulate octa calcium phosphate powder to enhance the biocompatibility and mechanical properties of the scaffold.
It has achieved improvement in the mechanical properties of the stent, maintained an interconnected pore structure, met the biocompatibility and mechanical strength requirements of the bone repair stent, and has broad application potential.
Smart Images

Figure CN116099043B_ABST
Abstract
Description
Technical Field
[0001] The present invention belongs to the field of bone tissue engineering, and particularly relates to a 3D printing ink for preparing a high-strength scaffold with an interconnected pore structure, and a preparation method and application thereof. Background Art
[0002] Bone defects caused by tumors, arthritis, trauma and osteoporosis seriously affect the health of patients. The bone's own repair ability is difficult to complete the repair of large bone defects. Among different treatment options, autologous bone transplantation is the gold standard for bone defect regeneration. Its bone repair material is taken from the patient himself and has good immune compatibility. However, its source is limited and it can also cause secondary damage, which limits its use. Allogeneic bone materials are often taken from donors, have potential risks of disease transmission and immune response, and are limited in source. Xenogeneic bone materials are taken from different species and have a wide source, but they often face more serious immune rejection reactions. Tissue engineering is an interdisciplinary field that has been emerging in recent years. It refers to the use of the principles and methods of life sciences and engineering sciences to develop functional tissues / organs as in vivo transplants to alleviate organ shortages or as in vitro models to study disease mechanisms and discover drugs. The successful application of bone tissue engineering can overcome the limitations of current treatment options.
[0003] Scaffolds are an important component of bone tissue engineering. Bone tissue engineering scaffolds can mimic the properties of the extracellular matrix, provide a template for cell adhesion, growth, proliferation, and differentiation, and provide structural support for newly formed tissues. They also play an important role in bone tissue integration and vascular regeneration. In addition, interconnected porosity is very important for the continued growth of bone tissue. The porous structure of bone tissue engineering scaffolds provides interconnected channels for cell migration, ion transport, cell-cell interaction, and the transport of oxygen, nutrients, and metabolites. Therefore, ideally, bone tissue engineering scaffolds should have the following characteristics: (1) an interconnected porous network; (2) biocompatibility and bioresorbability, with controllable degradation and resorption rates to match the growth of cells / tissues in vitro and / or in vivo; (3) a surface suitable for cell attachment, proliferation, and differentiation; and (4) mechanical properties that match those of the tissues at the implantation site.
[0004] The interconnected porous structure of bone tissue engineering scaffolds can provide channels for cell adhesion, growth, proliferation, differentiation and migration, as well as the transportation of oxygen, nutrients and metabolites, which is extremely important for the repair or regeneration of blood vessels, nerves, tissues / organs. 3D printing technology, also known as additive manufacturing technology, is defined by the American Society for Testing and Materials as "a process that uses three-dimensional model data to obtain entities by connecting materials, usually layer by layer, which is a process that is completely different from the manufacturing method of subtracting materials." It has the advantages of design freedom, large-scale customization, and the ability to manufacture complex structures. It can design, print and customize devices according to the actual situation of the patient's diseased area, and is widely used in personalized implantable medical devices, tissue engineering and regenerative medicine. In addition, 3D printing technology can also prepare tissue engineering scaffolds with different porosity and pore shape. At present, 3D printing technology has been used for the generation and transplantation of various tissues, including multi-layer skin, bone, vascular transplantation, tracheal splints, heart tissue and cartilage structures. In addition, although the scaffold obtained by the drying process maintains the integrity of the porous structure in the longitudinal direction, the overall shrinkage of the scaffold caused by the loss of water during the drying process has destroyed its side hole structure and cannot maintain the interconnected porous structure, which will affect the application prospects of the scaffold. The freeze-drying method dries by sublimating water in the frozen state of the scaffold. In this process, there is no tension caused by the migration of central water to the surface of the scaffold, and the scaffold can better maintain its original structure.
[0005] Humans have a long history of using biomaterials to repair damaged tissues. As early as 2,000 years ago, the Chinese and Romans used gold to make dentures to repair damaged teeth. According to the material type of biomaterials, they can be divided into metal materials, inorganic non-metal materials, polymer materials and composite materials. They each have advantages and disadvantages. However, single-component biomaterials often find it difficult to meet all the needs of biomedicine, especially in the field of bone tissue engineering, and it is difficult to use them alone as ideal bone repair materials. Compared with single-component biomaterials, the performance of composite materials is adjustable. Composite materials retain the unique advantages of single-component biomaterials, and also learn from and make up for the disadvantages of each component, optimize the configuration, and improve the shortcomings of single material application. In addition, from the perspective of material composition, natural bone can be regarded as a ceramic-organic composite material. The organic component of bone is mainly type I collagen, which itself will be a compliant material with high toughness, low modulus and other polymer-specific properties. The main inorganic component is HA crystals, which provide appropriate hardness for bones. The highly ordered structure of bone tissue assembled layer by layer from micro to macro gives it excellent mechanical strength. Organic / inorganic composite scaffolds can simulate the main components of bone tissue in terms of composition, and often have excellent biocompatibility and degradability. However, in addition to excellent biocompatibility and degradability, ideal bone repair scaffolds also require mechanical properties that match the mechanical properties of the tissue at the implant site. Currently, most organic / inorganic composite scaffolds often have poor mechanical properties and can only be used to repair bone defects in non-load-bearing areas. This is because although the current organic / inorganic composite scaffolds simulate the composition of bone tissue, unlike the ordered arrangement and bonding of collagen hydroxyapatite in natural bone tissue, the organic and inorganic components in the current organic / inorganic composite scaffolds are often simply mixed, which easily leads to the separation of inorganic and organic phases and reduces the mechanical properties. Developing a method to connect inorganic and organic components is an ideal strategy to improve the mechanical properties of current organic / inorganic composite scaffolds. Summary of the invention
[0006] The present invention provides the following technical solutions:
[0007] An ink comprising foamy solid and deionized water.
[0008] According to an embodiment of the present invention, the mass ratio of the foamy solid to deionized water is 1:(2-5).
[0009] According to an embodiment of the present invention, the foamed solid is prepared by the following method: modified octacalcium phosphate powder and sodium alginate powder are mixed and freeze-dried. Preferably, the mass ratio of the modified octacalcium phosphate powder to the sodium alginate powder is (4-6): (4-6). Preferably, the mixing is carried out in deionized water.
[0010] According to an embodiment of the present invention, the modified octacalcium phosphate powder is obtained by coating chitosan and tannic acid on the surface of the octacalcium phosphate powder.
[0011] The present invention also provides a method for preparing the ink. The method comprises wrapping octacalcium phosphate powder with tannic acid and chitosan to obtain the modified octacalcium phosphate powder; mixing the modified octacalcium phosphate powder and sodium alginate powder, freeze-drying the mixture, obtaining a foamy solid, and mixing the foamy solid with deionized water to obtain the ink.
[0012] According to an embodiment of the present invention, the preparation method specifically comprises the following steps:
[0013] (1) preparing octacalcium phosphate powder;
[0014] (2) preparing octacalcium phosphate powder coated with tannic acid: mixing the octacalcium phosphate powder prepared in step (1) with tannic acid to prepare octacalcium phosphate powder coated with tannic acid;
[0015] (3) preparing modified octacalcium phosphate powder: mixing chitosan with the octacalcium phosphate powder coated with tannic acid prepared in step (2), stirring and filtering to obtain octacalcium phosphate powder coated with chitosan and tannic acid, i.e., modified octacalcium phosphate powder;
[0016] (4) The modified octacalcium phosphate powder prepared in step (3) is mixed with sodium alginate powder, and then freeze-dried to obtain a foamy solid, which is then mixed with deionized water to obtain ink.
[0017] According to an embodiment of the present invention, in step (1), the octacalcium phosphate powder can be prepared by methods known in the art, such as by co-precipitation.
[0018] According to an embodiment of the present invention, the octacalcium phosphate powder is prepared by a coprecipitation method, specifically comprising: mixing ammonium dihydrogen phosphate, urea, calcium acetate and deionized water to obtain a mixed solution, and preparing the octacalcium phosphate powder by coprecipitation. Exemplarily, the preparation method of the mixed solution is as follows: dissolving ammonium dihydrogen phosphate and urea in deionized water, and then adding calcium acetate solution to obtain.
[0019] Preferably, the molar ratio of diammonium phosphate, urea, calcium acetate and deionized water is 12:9:30:(30000-60000), for example, 12:9:30:30000, 12:9:30:40000, 12:9:30:50000, 12:9:30:60000.
[0020] Preferably, the reaction conditions of the co-precipitation method include: reaction temperature of 80-95° C., and reaction time of 1-3 h.
[0021] According to an embodiment of the present invention, in step (2), the method for preparing the octacalcium phosphate powder coated with tannic acid comprises: dispersing the octacalcium phosphate powder into a buffer solution, dissolving tannic acid in the buffer solution, stirring and filtering to obtain the octacalcium phosphate powder.
[0022] Preferably, the buffer solution is selected from a tris-HCl buffer solution. Further, the pH value of the buffer solution is 7.5-9, for example, 7.5, 8, 8.5, 9.
[0023] Preferably, the mass ratio of the octacalcium phosphate powder to tannic acid is 1:(0.8-1.25), for example 1:(0.9-1.2), and for example 1:1, 1:1.1, 1:1.2.
[0024] Preferably, the mass ratio of the octacalcium phosphate powder to the tris-HCl buffer solution is 1:(50-100), for example, 1:50, 1:60, 1:70, 1:80, 1:90, 1:100.
[0025] Preferably, in step (2), the stirring temperature is room temperature and the stirring time is 12-48 hours.
[0026] According to an embodiment of the present invention, in step (3), the chitosan is provided by a chitosan solution. Preferably, the chitosan solution comprises chitosan and an acetic acid solution. Further, the concentration of the acetic acid solution is 0.05-0.2 mol / L. Further, the mass ratio of the chitosan to the acetic acid solution is 1:(500-2000), for example, 1:500:1:1000, 1:1500, 1:2000.
[0027] According to an embodiment of the present invention, in step (3), the mass ratio of the tannic acid-coated octacalcium phosphate powder, the chitosan solution and the deionized water is 2:(50-200):(300-500), for example, 2:100:(300-500), 2:(50-200):400, 2:50:(300-500), 2:200:(300-500).
[0028] According to an embodiment of the present invention, in step (3) and / or (4), the mixing is performed in deionized water.
[0029] According to an embodiment of the present invention, in step (3) and / or (4), the stirring temperature is 10-40°C, for example, room temperature; and the stirring time is 0.1-2h, for example, 0.5-1h.
[0030] According to an embodiment of the present invention, in step (4), the mass ratio of the modified octacalcium phosphate powder to the sodium alginate powder is (4-6): (4-6).
[0031] According to an embodiment of the present invention, in step (4), the mass ratio of the modified octacalcium phosphate powder to deionized water is (4-6):(150-300), for example, 5:(150-300), (4-6):200.
[0032] According to an embodiment of the present invention, in step (4), the freeze-drying conditions are: temperature of -20 to -40°C and time of 48 to 72 hours.
[0033] Preferably, in step (4), the mass ratio of the foamy solid and deionized water to prepare the ink is 1:(2-5), for example, 1:1, 1:2, 1:3, 1:4, 1:5.
[0034] According to a preferred embodiment of the present invention, the preparation method comprises:
[0035] (1) mixing ammonium dihydrogen phosphate, urea, calcium acetate and deionized water in a molar ratio of 12:9:30:(30000-60000), and reacting at 80-95° C. for 1-3 h to obtain octacalcium phosphate powder by a coprecipitation method;
[0036] (2) dispersing octacalcium phosphate powder into a tris-HCl buffer solution with a pH value of 7.5-9, dissolving tannic acid in the above solution, wherein the mass ratio of octacalcium phosphate powder, tannic acid, and tris-HCl buffer solution is 1:(0.8-1.25):(50-100), stirring at room temperature for 12-48 hours and filtering to obtain octacalcium phosphate powder coated with tannic acid;
[0037] (3) dissolving chitosan in 0.05-0.2 mol / L acetic acid solution, with the mass ratio of chitosan to acetic acid solution being 1:(500-2000), to prepare a chitosan solution;
[0038] (4) mixing chitosan solution and octacalcium phosphate powder coated with tannic acid in deionized water, wherein the mass ratio of chitosan solution, octacalcium phosphate powder coated with tannic acid and deionized water is 2:(50-200):(300-500), stirring at room temperature for 0.5-2h and filtering to obtain the modified octacalcium phosphate powder;
[0039] (5) The modified octacalcium phosphate powder and sodium alginate powder are mixed in deionized water, wherein the mass ratio of the modified octacalcium phosphate powder, sodium alginate powder and deionized water is (4-6):(4-6):(150-300), and then freeze-dried at -20 to -40°C for 48 to 72 hours to obtain a foamy solid, and the foamy solid is mixed with deionized water in a mass ratio of 1:(2-5) to obtain the ink.
[0040] The present invention also provides the use of the above ink, preferably for 3D printing, such as a printed product obtained by 3D printing. Preferably, the printed product is a bone repair scaffold.
[0041] The present invention also provides a bone repair scaffold, which is prepared by 3D printing the above ink.
[0042] According to an embodiment of the present invention, the bone repair scaffold includes modified octacalcium phosphate powder and sodium alginate powder.
[0043] According to an embodiment of the present invention, the mass ratio of the modified octacalcium phosphate powder to the sodium alginate powder is (4-6):(4-6), for example, 5:(4-6), (4-6):5.
[0044] According to an embodiment of the present invention, the bone repair scaffold has an interconnected pore structure.
[0045] According to an embodiment of the present invention, the compressive strength of the bone repair scaffold is 2-12 MPa, for example, 11 MPa.
[0046] The present invention also provides a method for preparing the above-mentioned bone repair scaffold, the preparation method comprising:
[0047] (S1) printing the ink using an extrusion 3D printing technology to obtain a formed stent model, and cross-linking and curing the stent model;
[0048] (S2) Drying the cured and cross-linked scaffold model to obtain the bone repair scaffold.
[0049] According to an embodiment of the present invention, in step (S1), the 3D printing technology printing can be performed using methods known in the art, such as layer-by-layer printing.
[0050] According to an embodiment of the present invention, in step (S1), the filling density of the scaffold model is 40%-60%, for example, 40%, 50%, or 60%.
[0051] According to an embodiment of the present invention, the cross-linking and curing refers to: immersing the scaffold model in a cross-linking and curing agent for a period of time.
[0052] Preferably, the cross-linking curing agent can be selected from substances known in the art, for example, the cross-linking curing agent includes HCl solution and / or CaCl2 solution. Further, the concentration of the HCl solution is 0.05-0.2 mol / L, for example, 0.1 mol / L, 0.15 mol / L, 2 mol / L. Further, the CaCl2 solution is 5-20 wt%, for example, 5 wt%, 10 wt%, 15 wt%, 20 wt%.
[0053] Exemplarily, the cross-linking and curing specifically includes: soaking the scaffold model in an HCl solution for 0.5-1.5 min, and then soaking the scaffold model in a CaCl2 solution for 3-6 h.
[0054] According to an embodiment of the present invention, in step (S2), the drying can be performed by methods known in the art, such as freeze drying or heating drying. Exemplarily, the freeze drying conditions are: the freeze drying temperature is -20-40°C, and the freeze drying time is 24-72h. Exemplarily, the heating drying conditions are: the heating temperature is 30-90°C, and the heating time is 12-72h.
[0055] According to an exemplary embodiment of the present invention, in step (S2), when freeze drying is performed, pre-freezing can also be performed before freeze drying. Preferably, the pre-freezing conditions include: a pre-freezing temperature of -20-40°C and a pre-freezing time of 2-5 hours.
[0056] According to a preferred embodiment of the present invention, the preparation method comprises:
[0057] (S1) printing the ink with an extrusion 3D printing technology at a filling density of 40%-60% to obtain a formed stent model, and placing the stent model in a 0.05-0.2 mol / L HCl solution and a 5-20 wt % CaCl2 solution for cross-linking and curing for 0.5-1.5 min and 3-6 h, respectively;
[0058] (S2) placing the solidified and cross-linked scaffold model in a freeze dryer for pre-freezing at -20 to -40°C for 2 to 5 hours, and then freeze-drying for 24 to 72 hours until completely dry to obtain the bone repair scaffold.
[0059] According to a preferred embodiment of the present invention, the preparation method comprises:
[0060] (S1) printing the ink with an extrusion 3D printing technology at a filling density of 40%-60% to obtain a formed stent model, and placing the stent model in a 0.05-0.2 mol / L HCl solution and a 5-20 wt % CaCl2 solution for cross-linking and curing for 0.5-1.5 min and 3-6 h, respectively;
[0061] (S2) Drying the cured and cross-linked scaffold model at 30-90° C. (such as 30° C.) for 12-72 h (such as 24 h) until it is completely dry to obtain the bone repair scaffold.
[0062] The present invention also provides a bone repair scaffold, which is obtained by the preparation method as described above.
[0063] According to an embodiment of the present invention, the bone repair scaffold includes sodium alginate and octacalcium phosphate, and the octacalcium phosphate is modified by tannic acid and chitosan.
[0064] According to an embodiment of the present invention, the bone repair scaffold has an interconnected pore structure.
[0065] Beneficial Effects
[0066] The printing ink of the present invention can be used to prepare a bone repair scaffold, which can not only meet the basic mechanical performance requirements of the scaffold, but also better maintain the original morphology and interconnected pore structure of the prepared scaffold.
[0067] The bone repair scaffold obtained by the preparation method of the present invention has good biocompatibility and mechanical strength, and also has an interconnected pore structure. These interconnected pore structures provide channels for cell adhesion, growth, proliferation, differentiation and migration, as well as the transportation of oxygen, nutrients and metabolites, and have broad application potential. BRIEF DESCRIPTION OF THE DRAWINGS
[0068] Figure 1 Mechanical properties tests of OCP / SA (Comparative Example 1), TA-OCP / SA (Comparative Example 2) and CS-TA-OCP / SA (Example 2) 3D printed bone repair scaffolds; wherein A represents compressive strength, B represents Young's modulus, C represents peak strain, and D represents stress-strain curve.
[0069] Figure 2 It is a test diagram of the stent of Example 1; wherein A is the lateral channel structure of the stent, B is the axial channel structure of the stent, and C represents the compressive strength of the stent.
[0070] Figure 3 This is an optical image of the bracket of Example 2. DETAILED DESCRIPTION
[0071] The technical scheme of the present invention will be further described in detail below in conjunction with specific embodiments. It should be understood that the following embodiments are only exemplary descriptions and explanations of the present invention and should not be construed as limiting the scope of protection of the present invention. All technologies implemented based on the above content of the present invention are included in the scope that the present invention is intended to protect.
[0072] Unless otherwise specified, the raw materials and reagents used in the following examples are commercially available or can be prepared by known methods.
[0073] Example 1
[0074] 3D printing to prepare bone repair scaffolds:
[0075] (1) Preparation of octacalcium phosphate powder: 0.009 mol NH4H2PO4 and 0.03 mol CO(NH2)2 were mixed with 300 mL of distilled water, and then magnetically stirred at room temperature to completely dissolve them to prepare solution A. At the same time, 0.0012 mol Ca(CH3COO)2·H2O was dissolved in 300 mL of distilled water to prepare solution B. Subsequently, solution B was added dropwise to solution A and stirred for 5 minutes to form solution C. Solution C was then heated in a 90°C water bath and vigorously stirred for 2 hours. After the reaction was completed, the obtained precipitate was filtered and washed with deionized water 3 times and anhydrous ethanol 2 times. The filtered product was dried at 60°C for 24 hours to obtain octacalcium phosphate powder.
[0076] (2) Preparation of tannin-modified octacalcium phosphate powder: Prepare a 0.05M tris-HCl buffer solution with a pH of 8.5. Take 4 g of the prepared octacalcium phosphate powder and disperse it in 150 mL of a 0.05M tris-HCl buffer solution with a pH of 8.5, and stir until it is completely dispersed to prepare a solution A.
[0077] Take 4 g of tannic acid and dissolve it in 50 mL of the above tris-HCl buffer solution, stir until completely dissolved, and form solution B. Add solution B drop by drop into solution A and stir to form solution C. Solution C is stirred at room temperature for 24 hours. After the reaction is completed, the obtained precipitate is filtered and repeatedly washed with deionized water until the filtrate is colorless. The product after suction filtration is dried at 60°C for 24 hours to obtain tannin-modified octacalcium phosphate powder.
[0078] (3) Preparation of octacalcium phosphate powder coated with chitosan and tannic acid: 2 g of the prepared tannin-modified octacalcium phosphate powder was dispersed in 400 mL of deionized water to prepare solution C. 1 g of chitosan was dissolved in 1 L of 1 wt% acetic acid solution to prepare a 1 g / L chitosan solution, i.e., solution D. 100 mL of solution D was added dropwise to 400 mL of solution C, stirred for 0.5 h, filtered and repeatedly washed with deionized water, and the precipitate was obtained to obtain octacalcium phosphate powder modified with tannic acid and chitosan, which was named octacalcium phosphate powder coated with chitosan and tannic acid.
[0079] (4) Preparation of "ink" by in-situ composite method: Specifically, 6g of the prepared tannic acid and chitosan-modified octacalcium phosphate was dispersed in 100mL of deionized water, and the mixture was stirred continuously with a magnetic stirrer to make it evenly dispersed. 4g of sodium alginate powder was added to the above solution, and stirring was continued until the sodium alginate was completely dissolved, so that the sodium alginate, tannic acid and chitosan-modified octacalcium phosphate were evenly mixed. The obtained solution was frozen in a refrigerator at -20°C for 12h, and then placed in a freeze dryer at -20°C for freeze drying for 48h until completely freeze-dried. The "foamy" solid obtained after freeze drying was mixed with deionized water at a mass ratio of 1:3, and stirred until completely uniform to obtain the "ink" required for 3D printing.
[0080] (5) Printing porous scaffolds: Use modeling software to construct cylindrical models of Φ15×5mm and Φ15×30mm and use slicing software to export slicing files with a layer thickness of 0.6mm and a filling density of 50%. Then, use an extrusion 3D printer to print "ink" layer by layer under the control of gcode code to obtain a porous scaffold. After printing, octacalcium phosphate / sodium alginate scaffolds modified with tannic acid and chitosan were obtained. The octacalcium phosphate / sodium alginate scaffolds modified with tannic acid and chitosan were placed in a 0.1M HCl solution and soaked for 1.5min to promote further protonation of chitosan. After that, all scaffolds were cross-linked in a 10wt% CaCl2 solution for 5h until solidified, and the cross-linked scaffolds were washed with deionized water and placed in a freeze dryer at -30℃ for pre-freezing for 5h, and then freeze-dried for 36h until completely dry to obtain a scaffold named CS-TA-OCP / SA-D.
[0081] Example 2
[0082] The preparation method of this embodiment is basically the same as that of Example 1, except that in step (5), the cross-linked tannic acid and chitosan modified octacalcium phosphate / sodium alginate scaffold is placed in an oven for drying (drying temperature is 30° C., drying time is 24 h), and is named CS-TA-OCP / SA.
[0083] Comparative Example 1
[0084] (1) Take 6g of the prepared octacalcium phosphate and disperse it in 100mL of deionized water. Use a magnetic stirrer to stir continuously to make it evenly dispersed. Add 4g of sodium alginate powder to the above solution, and continue stirring until the sodium alginate is completely dissolved, so that the sodium alginate and octacalcium phosphate are evenly mixed. Freeze the resulting solution in a -20°C refrigerator for 12h, and then place it in a freeze dryer at -20°C for freeze drying for 48h until it is completely freeze-dried. Mix the "foamy" solid obtained after freeze drying with deionized water in a mass ratio of 1:3, stir until completely uniform, and obtain the "ink" required for 3D printing.
[0085] (2) Use modeling software to construct Φ15×5mm and Φ15×30mm cylindrical models and use slicing software to export slicing files, with a layer thickness of 0.6mm and a filling density of 50%. Then, use an extrusion 3D printer to print "ink" layer by layer under the control of the gcode code to obtain a porous scaffold. After printing, the octacalcium phosphate / sodium alginate scaffold was obtained. The octacalcium phosphate / sodium alginate scaffold was soaked in 0.1M HCl solution for 1.5min to promote further protonation of chitosan. After that, all scaffolds were cross-linked in 10wt% CaCl2 solution for 5h until solidified, and the cross-linked scaffold was washed with deionized water and placed in an oven to dry, named OCP / SA.
[0086] Comparative Example 2
[0087] (1) Take 6g of the prepared tannin-modified octacalcium phosphate and disperse it in 100mL of deionized water. Use a magnetic stirrer to continuously stir it to make it evenly dispersed. Add 4g of sodium alginate powder to the above solution, and continue stirring until the sodium alginate is completely dissolved, so that the sodium alginate and the tannin-modified octacalcium phosphate are evenly mixed. Freeze the resulting solution in a -20°C refrigerator for 12h, and then place it in a freeze dryer at -20°C for freeze drying for 48h until it is completely freeze-dried. Mix the "foamy" solid obtained after freeze drying with deionized water in a mass ratio of 1:3, stir until it is completely uniform, and obtain the "ink" required for 3D printing.
[0088] (2) Use modeling software to construct cylindrical models of Φ15×5mm and Φ15×30mm and use slicing software to export slicing files, with a layer thickness of 0.6mm and a filling density of 50%. Then, use an extrusion 3D printer to print "ink" layer by layer under the control of the gcode code to obtain a porous scaffold. After printing, a tannin-modified octacalcium phosphate / sodium alginate scaffold was obtained. The tannin-modified octacalcium phosphate / sodium alginate scaffold was immersed in a 0.1M HCl solution for 1.5min to promote further protonation of chitosan. After that, all scaffolds were cross-linked in a 10wt% CaCl2 solution for 5h until solidified, and the cross-linked scaffolds were washed with deionized water and placed in an oven to dry, named TA-OCP / SA.
[0089] Test Example 1
[0090] The compressive performance and compressive strength of the stents prepared in Comparative Example 1, Comparative Example 2 and Example 2 were measured according to the Chinese national standard GB / T 8489-2006 (N=3, 3 samples per group) using a stent of Φ15×30 mm using a universal testing machine.
[0091] from Figure 1The experimental results of D show that the compressive strength of Example 2 reaches 68.17±10.26MPa, the compressive strength of Comparative Example 1 reaches 44.86±7.92MPa, and the compressive strength of Comparative Example 2 reaches 18.36±1.26MPa.
[0092] Compared with Example 1, the mechanical strength of the stent obtained in Example 2 was significantly reduced. Figure 2 As shown in C, it still maintains a relatively high compressive strength (about 11MPa), which can meet the mechanical strength requirements of cancellous bone (2-12MPa).
[0093] Test Example 2
[0094] The cell viability of BMSCs cells cultured in the porous scaffold extract prepared in Example 2, Comparative Example 1 and Comparative Example 2 was determined by cell counting kit-8 (CCK-8). The scaffold extract was prepared according to ISO10993-12 2017. In the experiment, BMSCs were cultured at 8×10 4 cells / cm 2 The density of the prepared porous scaffolds was co-cultured with the extracts of Example 2, Comparative Example 1, and Comparative Example 2 in a 96-well plate and placed in a cell culture incubator at 37°C and 5% CO2. After culturing for 24 hours, 10 μL of CCK-8 solution was added to each well. After incubation for 1 hour, the optical density (OD) of each well was measured at 450 nm using a microplate reader. The calculation method of cell viability is:
[0095] Cell viability = (OD 实验组 -OD 空白组 ) / (OD 对照组 -OD 空白组 )
[0096] When the cell viability is higher than 70%, the scaffold can be considered to be non-cytotoxic; when the cell viability is lower than 70%, the scaffold is considered to be cytotoxic.
[0097] The experimental results show that the porous scaffolds prepared in Example 2, Comparative Example 1, and Comparative Example 2 reached 97.6±14.4%, 79.0±17.4%, and 82.9±2.2%, respectively, which confirms that the scaffold prepared using the ink of Example 2 has no biotoxicity and better biocompatibility, and has application potential as a bone repair scaffold.
[0098] The biocompatibility of the porous scaffold of Example 1 is substantially equivalent to that of Example 2.
[0099] Test Example 3
[0100] The porous scaffolds prepared in Example 1 and Example 2 were taken and their morphologies and side hole structures were observed under a stereo microscope.
[0101] The results show that the pore structure of the scaffold of Example 2 shrinks during the drying process. Therefore, the pore structure of the 3D printed scaffold of Example 2 collapses slightly compared with Example 1. Figure 3 .
[0102] Compared with the 3D printed bracket obtained in Example 2, the bracket obtained in Example 1 better maintains the channel structure of the interconnected side holes, showing complete side holes, see Figure 2 As shown in A and B.
[0103] The above test examples show that:
[0104] By comparing Example 2 with Comparative Example 1-2, it can be seen that the present invention prepares the "ink" by the in-situ composite method, and when the "ink" is printed to prepare a porous stent, the mechanical properties of the stent can be improved;
[0105] By comparing Example 1 and Example 2, it can be seen that the octacalcium phosphate / sodium alginate scaffold obtained by freeze-drying in Example 1 can still meet the basic mechanical performance requirements of the scaffold, and can better maintain the original morphology and interconnected pore structure of the prepared scaffold.
[0106] The above is a description of the exemplary embodiments of the present invention. However, the protection scope of the present application is not limited to the above embodiments. Any modification, equivalent substitution, improvement, etc. made by those skilled in the art within the spirit and principle of the present invention shall be included in the protection scope of the present invention.
Claims
1. A method for preparing ink, It is characterized in that The ink comprises a foamy solid and deionized water; the mass ratio of the foamy solid to the deionized water is 1:(2-5); The method for preparing the ink specifically comprises the following steps: (1) Preparing octacalcium phosphate powder; (2) Preparing octacalcium phosphate powder coated with tannic acid: mixing the octacalcium phosphate powder prepared in step (1) with tannic acid in a buffer solution, filtering and drying, to prepare octacalcium phosphate powder coated with tannic acid; the mass ratio of the octacalcium phosphate powder to tannic acid is 1:(0.8-1.25); (3) Preparing modified octacalcium phosphate powder: dispersing the tannic acid-coated octacalcium phosphate powder prepared in step (2) in deionized water, then mixing with a chitosan solution, stirring and filtering to obtain octacalcium phosphate powder coated with chitosan and tannic acid, i.e., modified octacalcium phosphate powder; (4) The modified octacalcium phosphate powder prepared in step (3) is mixed with sodium alginate powder in deionized water, and then freeze-dried to obtain a foamy solid, which is then mixed with deionized water to prepare ink; the mass ratio of the modified octacalcium phosphate powder to the sodium alginate powder is (4-6): (4-6).
2. The preparation method according to claim 1, It is characterized in that In step (1), the octacalcium phosphate powder is prepared by a coprecipitation method, which specifically includes: mixing ammonium dihydrogen phosphate, urea, calcium acetate and deionized water to obtain a mixed solution, and preparing the octacalcium phosphate powder by a coprecipitation method; The molar ratio of diammonium phosphate, urea, calcium acetate and deionized water is 12:9:30:(30000-60000); The reaction conditions of the coprecipitation method include: reaction temperature of 80-95° C. and reaction time of 1-3 h.
3. The preparation method according to claim 1, It is characterized in that In step (2), the method for preparing the octacalcium phosphate powder coated with tannic acid comprises: dispersing the octacalcium phosphate powder into a buffer solution, dissolving tannic acid in the buffer solution, stirring, filtering and drying to obtain the result; The buffer solution is selected from tris-HCl buffer solution; the pH value of the buffer solution is 7.5-9; The mass ratio of the octacalcium phosphate powder to the tris-HCl buffer solution is 1:(50-100); In step (2), the stirring temperature is room temperature and the stirring time is 12-48 h.
4. The preparation method according to claim 1, It is characterized in that In step (3), the chitosan solution comprises chitosan and acetic acid solution; the concentration of the acetic acid solution is 0.05-0.2 mol / L; the mass ratio of the chitosan to the acetic acid solution is 1:(500-2000); In step (3), the mass ratio of the tannic acid-coated octacalcium phosphate powder, the chitosan solution and the deionized water is 2: (50-200): (300-500).
5. The preparation method according to claim 1, It is characterized in that In step (3), the stirring temperature is 10-40°C and the stirring time is 0.1-2h.
6. The preparation method according to claim 1, It is characterized in that In step (4), the mass ratio of the modified octacalcium phosphate powder to deionized water is (4-6): (150-300); In step (4), the freeze-drying conditions are: temperature of -20 to -40°C and time of 48 to 72 h; In step (4), the foamy solid is mixed with deionized water to prepare the ink in a mass ratio of 1:(2-5).
7. A kind of ink, It is characterized in that The ink is obtained by the preparation method according to any one of claims 1 to 6.
8. The ink according to claim 7, It is characterized in that The ink comprises a foamy solid and deionized water; the mass ratio of the foamy solid to the deionized water is 1:(2-5); The foam solid is prepared by the following method: modified octacalcium phosphate powder and sodium alginate powder are mixed and freeze-dried to obtain the foam solid; the mass ratio of the modified octacalcium phosphate powder and the sodium alginate powder is (4-6): (4-6); The modified octacalcium phosphate powder is obtained by coating chitosan and tannic acid on the surface of the octacalcium phosphate powder.
9. Use of the ink according to claim 7 or 8 in 3D printing.
10. A bone repair scaffold, It is characterized in that The bone repair scaffold is prepared by 3D printing the ink according to claim 7 or 8.
11. The bone repair scaffold according to claim 10, It is characterized in that The bone repair scaffold comprises modified octacalcium phosphate powder and sodium alginate powder; The mass ratio of the modified octacalcium phosphate powder to the sodium alginate powder is (4-6): (4-6); The bone repair scaffold has an interconnected pore structure; The compressive strength of the bone repair scaffold is 2-12 MPa.
12. A method for preparing the bone repair scaffold according to claim 10 or 11, It is characterized in that The preparation method comprises: (S1) printing the ink using an extrusion 3D printing technology to obtain a formed stent model, and cross-linking and curing the stent model; (S2) Drying the cured and cross-linked scaffold model to obtain the bone repair scaffold.
13. The method for preparing the bone repair scaffold according to claim 12, It is characterized in that In step (S1), the filling density of the scaffold model is 40%-60%; The cross-linking and curing refers to: immersing the scaffold model in a cross-linking curing agent for a period of time.
